# Go-to-Market Strategy v3.0 — AI Agent Governance

**Version:** 3.0  
**Date:** March 2026  
**Previous Version:** [v2.0 - Coverage Governance GTM](../archive/v2-coverage-governance/marketing/gtm_pps.md)

---

## The Shift From v2

**v2.0 GTM:** "We help teams govern code quality"
- Feature education
- Broad buyer (Platform Engineers)
- Long sales cycle

**v3.0 GTM:** "We remove three specific growth blockers that are stopping AI adoption"
- Problem education
- Executive buyer (CTO, VP Engineering)
- Short, high-urgency sales cycle

---

## One-Sentence Positioning

> **Nolapse is the infrastructure that lets you scale AI agents without hitting the wall that stops your competitors.**

---

## The Three Blockers (Sales Messaging)

### Blocker 1: Agent Scaling Wall

**Prospect Signal:** "We're running Cursor/Claude Code/Devin across multiple teams"

**Your Response:**
> "You're hitting or will hit a ceiling. Right now you can review every agent PR. In 60–90 days when you have 5–10 agents, review becomes the bottleneck. You face a choice: slow down to review everything, or stop reviewing and accumulate debt. Nolapse removes that choice. Every agent PR is measured against baseline. Pass/fail is automated. PRs that fail get specific feedback the agent can act on. You can run 50 agents with the same overhead as 1."

**Demo:** Agent PR fails → receives specific feedback → self-corrects → passes (3 minutes)

---

### Blocker 2: Enterprise Deal Stall

**Prospect Signal:** "We're trying to close our first enterprise customer"

**Your Response:**
> "Enterprise procurement is asking a specific question now: 'How do you govern code written by AI agents?' Most companies have no answer. Deals sit in security review for 60–90 days. Nolapse is the answer. It provides a complete, auditable, Git-native record of every agent PR, every coverage decision, every pass/fail. Immutable, timestamped, keyed by agent token type. Auditor verifies it in 2 days instead of 60."

**Proof Point:** Generate sample audit export showing 100+ agent PRs with coverage deltas and token attribution

---

### Blocker 3: Production Incident Risk

**Prospect Signal:** "We had a production incident recently that we traced to an agent PR"

**Your Response:**
> "You're the person who will be asked to explain the incident when it happens. Right now you cannot answer 'which agent PR caused this?' without weeks of git archaeology. With Nolapse, you have the answer in 2 minutes. More importantly, coverage regressions fail before they merge. The incident is less likely in the first place."

**Proof Point:** Query a live log. Show incident → identify PR → identify agent token → show coverage delta

---

## Prospect Qualification Matrix

If prospect answers YES to any TWO of these, they have a blocker Nolapse removes:

1. Running 3+ AI agents (Cursor, Claude Code, Copilot, Devin)?
2. Trying to close enterprise deals requiring security reviews?
3. Production incident in last 6 months traced to a PR?
4. Platform Team spends 20%+ of time reviewing agent PRs?
5. SOC 2 or ISO 27001 audit planned in 12 months?
6. Competitors using AI agents more aggressively?

**Two yes answers = qualified prospect. The combination tells you which blocker to lead with.**

---

## Pitch Hierarchy by Prospect Signals

| Prospect Signal | Lead Blocker | Supporting | Follow-up Questions |
| --- | --- | --- | --- |
| "We're running Cursor/Claude/Devin across teams" | Agent Scaling Wall | Incident Risk | How many agents? How many hours/week on review? |
| "Trying to close first enterprise customer" | Enterprise Deal Stall | Compliance Evidence | Where's the deal stuck? Security review duration? |
| "Had a production incident recently" | Incident Risk | Agent Scaling Wall | Was it traced to specific PR? How long root cause took? |
| "Doing SOC 2 audit" | Enterprise Deal Stall | Agent Scaling Wall | Does audit ask about AI code governance? |
| "Our agents write a lot of code" | Agent Scaling Wall | Incident Risk | Can you review all of it? Risk of gaps? |
| "Want to run more agents but unsure it's safe" | Agent Scaling Wall + Incident Risk | Enterprise Readiness | What's the safety concern? How do you measure it? |

---

## Sales Conversation Flow

### Discovery (10 minutes)

1. **Opening:** "Are you running multiple AI agents today?"
2. **Probe:** Depending on answer, ask about scaling challenges, enterprise requirements, or incident history
3. **Qualify:** Use the matrix above. Look for 2+ yes answers
4. **Identify lead blocker:** Which of the three is most immediate?

### Education (15 minutes)

1. **Tell the story:** "Every team running agents hits this wall..."
2. **Show the blocker:** "Here's specifically what happens" (use Blocker 1/2/3 messaging)
3. **Show the solution:** "Nolapse solves this with X, Y, Z"
4. **Prove it:** 3-minute demo of the specific blocker removal

### Commitment (5 minutes)

1. **Objection handling** (if needed)
2. **Next step:** Design partner agreement, pilot, PoC scope
3. **Timeline:** When do they need this?

---

## Key Sales Objections

### "We review every agent PR manually — we don't need this."

> "You do now. You won't in 6 months when you have twice as many agents and half the time per PR. The question is not whether you need this today. It's whether you want to be in reactive crisis mode when you do, or have the infrastructure already in place."

### "Our agents write good tests."

> "Your agents write tests that pass the checks they're given. They don't know what the coverage baseline was when the branch was created. They don't know which files dropped coverage. Nolapse tells them — specifically, per file, per line. Good tests come from good feedback."

### "We're not big enough for this yet."

> "The companies that implement governance before they need it are the ones that scale past the wall. The ones that implement it after hitting the wall spend a quarter recovering. You're either building the infrastructure or deferring the wall."

### "This is just coverage reporting."

> "Codecov shows you what your coverage is. Nolapse enforces it per agent and produces an audit trail keyed by token type. These are categorically different. We're the governance layer above reporting tools."

### "We don't have enterprise deals yet."

> "Great. Implement governance now. When your first enterprise deal comes in and they ask 'how do you govern AI code?', you're not in a stall—you move the deal."

---

## Competitive Positioning

### vs Codecov / Codacy

- **Codecov:** Shows coverage
- **Nolapse:** Enforces coverage + provides audit trails + enables agent self-correction

### vs GitHub / Enterprise Tooling

- **GitHub Copilot:** Writes code. No governance.
- **Nolapse:** Governs code written by any tool (Copilot, Claude Code, Cursor, Devin, or human)

### vs Manual Review

- **Manual Review:** Doesn't scale. Not auditable. Consumes engineering time.
- **Nolapse:** Scales to 50+ agents. Auditable. Zero manual overhead.

---

## Early Customer Criteria (Design Partner Phase)

1. **Must be running 3+ AI agents** (Cursor, Claude Code, etc.)
2. **Must have engineering bandwidth** to integrate with CI/CD
3. **Willing to provide feedback** on positioning and product
4. **Have a growth blocker** we can demonstrably solve
5. **Reference-able** (willing to be case study post-launch)

---

## Outreach Messaging by Channel

### LinkedIn / Twitter / Email Outreach

**Lead with the blocker, not the tool.**

**Bad:** "Try Nolapse — the coverage enforcement platform for AI agents"

**Good:** "Every team running 5+ AI agents hits the same wall: manual review becomes the bottleneck. Here's how you scale past it → [3-min demo]"

---

### Product Hunt / Launch Announcements

**Lead with the growth constraint.**

**Bad:** "Nolapse: Coverage governance for engineering teams"

**Good:** "The infrastructure that lets your AI agents scale without limits — removes the manual review bottleneck that stops every company"

---

### Sales Deck Structure

1. **Hook:** "If you're running multiple AI agents, you're hitting one of three walls"
2. **The Wall:** Deep dive on whichever blocker is most relevant
3. **The Cost:** Revenue impact, team impact, competitive impact
4. **The Solution:** How Nolapse specifically removes it
5. **Proof:** Live demo of blocker removal
6. **Timeline:** "This is happening now. Your competitors are solving it now."
7. **Next:** Design partner agreement or pilot scope

---

## Success Metrics

| Metric | v2.0 Target | v3.0 Target | Improvement |
| --- | --- | --- | --- |
| Sales cycle length | 60–90 days | 14–21 days | 4–6x faster |
| Buyer authority | Platform Engineer | CTO/VP Engineering | Higher budget |
| Deal urgency | Feature evaluation | Risk mitigation | Higher close rate |
| Design partners (first 90 days) | 3–5 | 8–12 | 2–3x more |
| First enterprise deal close | Day 120+ | Day 45–60 | 2–3x faster |

---

## Related Documents

- **[Strategic Positioning v3.0](../product/strategic-positioning.md)** — Detailed blocker positioning
- **[The Three Blockers](../product/ai-agent-governance/)** — Deep dive on each blocker
- **[Competitive Landscape](competitive-landscape.md)** — How we position vs alternatives

---

## Previous Version

**[View v2.0 GTM Strategy](../archive/v2-coverage-governance/marketing/gtm_pps.md)**

The v2 GTM was feature-focused and had longer sales cycles. v3.0 GTM is blocker-focused with shorter, higher-urgency cycles.

---

*Go-to-Market Strategy v3.0 | March 2026*
